Ivermectin for COVID-19: real-time meta analysis of 95 studies
95 ivermectin COVID-19 controlled studies. 82% improvement for prophylaxis, p < 0.0001. 62% improvement for early treatment, p < 0.0001. 42% improvement for late treatment, p < 0.0001. ivmmeta
COLLUSION: Merck, Big Pharma trying to kill off all generic ivermectin production because it’s cutting into profits – NaturalNews.com https://www.naturalnews.com/2023-03-02-big-pharma-kill-ivermectin-cutting-profits.html